Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
100 hedge funds and large institutions have $589M invested in Albireo Pharma Inc in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 13 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less capital invested
Capital invested by funds: $621M → $589M (-$31.8M)
7% less funds holding
Funds holding: 107 → 100 (-7)
25% less call options, than puts
Call options by funds: $2.63M | Put options by funds: $3.52M
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$11.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$8.12M |
| 3 |
CC
Chicago Capital
Chicago,
Illinois
|
+$2.51M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.39M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$6.93M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$4.69M |
| 3 |
AG
Artal Group
Luxembourg
|
-$3.69M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.26M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.17M |
ALBO Hedge Fund Activity: Q1 2021 in Review
100 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2021, worth a combined $589M — down 5.1% from $621M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ALBO and 6 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 40 added.
The largest buyer was Rice Hall James & Associates, adding an estimated $11.6M. The largest seller was Marshall Wace, cutting an estimated $6.93M.
- 100 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2021, down from 107 in Q4 2020.
- Funds reported $589M of Albireo Pharma Inc stock for Q1 2021, down 5.1% quarter-over-quarter.
- 6 funds opened new Albireo Pharma Inc positions in Q1 2021 and 13 closed out, a net change of -7 holders.
- The largest Albireo Pharma Inc buyer in Q1 2021 was Rice Hall James & Associates, an estimated $11.6M added.
- The largest Albireo Pharma Inc seller in Q1 2021 was Marshall Wace, an estimated $6.93M sold.
Based on aggregated 13F filings for Q1 2021.